_________
false
C003
אקס טי אל ביופרמסוטיקלס בע"מ
2
Public
X T L BIOPHARMACEUTICALS LTD
4313
Corporation no:
520039470
Stock Exchange/Market:
אקס טי אל
1996
381
Hasapir
3
,
Nes Ziona
76100
,
,
Tel:
08-9304444
,
Fax:
08-9304445
E.mail address:
rcohen@xtlbio.com
Date of transmission:
07/01/2008
Time of broadcast:
16:15
16:08:56
Reference:
2008-02-007668
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
CEO Presentation at the 26th JP Morgan Healthcare Conference
JPMorganFINAL_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
07/01/2008
Name of the Signatory:
:
Kantor Ronen
,
,
Position of Signatory in the reporting corporation:
Legal Consultant & Corporate Secretary
Abba Hillel Silver
Telephone:
03-6133371
,
Facsimile:
03-6133372
,
E-mail:
rkantor@kantor-law.com
2